Xtx Topco LTD Geron Corp Transaction History

Xtx Topco LTD

$1.72 Billion
Q3 2025

A detailed history of Xtx Topco LTD transactions in Geron Corp stock. As of the latest transaction made, Xtx Topco LTD holds 165,516 shares of GERN stock, worth $185,377. This represents 0.01% of its overall portfolio holdings.

Number of Shares

165,516

Previous 124,522 32.92%

Holding current value

$185,377

Previous $175,000 29.14%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$1.1 - $1.47 $45,093 - $60,261	40,994 Added 32.92%	165,516 $226,000
Q2 2025 Aug 12, 2025	BUY	$1.18 - $1.62 $133,367 - $183,097	113,023 Added 982.89%	124,522 $175,000
Q1 2025 May 07, 2025	SELL	$1.59 - $3.6 $332,858 - $753,642	-209,345 Reduced 94.79%	11,499 $18,000
Q4 2024 Feb 13, 2025	BUY	$3.3 - $4.44 $692,765 - $932,084	209,929 Added 1923.31%	220,844 $781,000
Q3 2024 Nov 14, 2024	SELL	$4.17 - $4.99 $102,190 - $122,284	-24,506 Reduced 69.18%	10,915 $49,000

Q2 2024 Aug 12, 2024	SELL	$3.1 - $5.09 $77,546 - $127,326	-25,015 Reduced 41.39%	35,421 $150,000
Q1 2024 May 13, 2024	SELL	$1.75 - $3.44 $338,380 - $665,158	-193,360 Reduced 76.19%	60,436 $199,000
Q4 2023 Feb 13, 2024	BUY	$1.74 - $2.31 $344,436 - $457,269	197,952 Added 354.47%	253,796 $535,000
Q3 2023 Nov 13, 2023	BUY	$2.11 - $3.28 $117,830 - $183,168	55,844 New	55,844 $118,000
Q1 2023 May 12, 2023	SELL	$2.14 - $3.4 $24,436 - $38,824	-11,419 Reduced 18.0%	52,016 $112,000
Q4 2022 Feb 14, 2023	BUY	$2.03 - $2.42 $54,028 - $64,408	26,615 Added 72.28%	63,435 $153,000
Q3 2022 Nov 14, 2022	BUY	$1.67 - $2.94 $1,982 - $3,489	1,187 Added 3.33%	36,820 $86,000
Q2 2022 Aug 15, 2022	SELL	$1.19 - $1.65 $23,590 - $32,709	-19,824 Reduced 35.75%	35,633 $55,000
Q1 2022 May 13, 2022	BUY	$0.99 - $1.6 $54,902 - $88,731	55,457 New	55,457 $75,000

Others Institutions Holding GERN

# of Institutions

288

Shares Held

502M

Call Options Held

643K

Put Options Held

276K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $423M
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account